Editorial: Interventional therapy of hepatocellular carcinoma
Front Mol Biosci
.
2022 Aug 25:9:972207.
doi: 10.3389/fmolb.2022.972207.
eCollection 2022.
Authors
Jiansong Ji
1
,
Xiaoming Yang
2
,
Jianyuan Luo
3
,
Ivana Vucenik
4
,
Shuheng Jiang
5
Affiliations
1
Lishui Central Hospital, Lishui, China.
2
Radiology, University of Washington, Seattle, WA, United States.
3
Health Science Centre, Peking University, Beijing, China.
4
University of Maryland, School of Medicine, Baltimore, MD, United States.
5
Shanghai Cancer Institute, Shanghai, China.
PMID:
36090040
PMCID:
PMC9453639
DOI:
10.3389/fmolb.2022.972207
No abstract available
Keywords:
ACE; HCC; Interventional therapy; RFA—radiofrequency ablation; treatment innovations.
Publication types
Editorial
Grants and funding
R01 EB028095/EB/NIBIB NIH HHS/United States